Psilocybin, an active ingredient in magic mushrooms, has been a prodigious interest in the US with several clinical trials on its effectiveness to treat and reduce symptoms of depression, anxiety, and other mood disorders. The results from these clinical trials have been impeccable, and a possible breakthrough treatment for various ailments in the pharmaceutical industry.
Psilocybin is produced by more than 180 kinds of mushrooms around the world, most likely as a defense mechanism. Scientists believe that psilocybin suppresses the appetite of predatory insects such as ants — causing them to feel full before devouring the entire mushroom. Humans, on the other hand, are prone to tripping. The fact that
Read about Merlin Sheldrake’s new book on the topic of the fungal world, and how fungi will shape our future.
Tom and Sherri Eckert join us to talk about their initiative to legalize Psilocybin services in Oregon (#PSI2020).
Seeking supernormal inspiration, I determined to visit the Royal Botanical Gardens and do some perceptual fieldwork there. This glorious plant sanctuary provides a wonderful opportunity to confront some of nature’s more exotic creations housed safely within Kew’s splendid Victorian greenhouses.
Activity in the medial prefrontal cortex was consistently decreased by psilocybin, which is of interest as this area has been observed to be hyperactive in people experiencing major depressive episodes. Mindfulness meditation has also been found to reduce activity in these same brain regions.